Entyvio and Hydroxocobalamin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Entyvio (vedolizumab) and Hydroxocobalamin (hydroxocobalamin). Common drug interactions include carpal tunnel syndrome among females and complications of transplanted kidney among males.
The phase IV clinical study analyzes what interactions people have when they take Entyvio and Hydroxocobalamin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Entyvio?
Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.
What is Hydroxocobalamin?
Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.
14 people who take Entyvio and Hydroxocobalamin together, and have interactions are studied.

What are the common drug interactions of Entyvio and Hydroxocobalamin, by gender? *:
female:
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Dyspnoea (difficult or laboured respiration)
- Faeces discoloured
- Fatigue (feeling of tiredness)
- Gait disturbance
- Haematochezia (passage of stools containing blood)
- Haemorrhage (bleeding)
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Hypoaesthesia (reduced sense of touch or sensation)
- Limb discomfort (discomfort in leg)
male:
- Complications of transplanted kidney
- Cough
- Glomerulonephritis proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys)
- Haematuria (presence of blood in urine)
- Pancreatitis acute (sudden inflammation of pancreas)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Suicidal ideation
What are the common drug interactions of Entyvio and Hydroxocobalamin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Complications of transplanted kidney
- Glomerulonephritis proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys)
- Haematuria (presence of blood in urine)
30-39:
- Pancreatitis acute (sudden inflammation of pancreas)
- Splenic vein thrombosis (blood clot in splenic vein)
40-49:
- Suicidal ideation
50-59:
- Haematochezia (passage of stools containing blood)
- Haemorrhage (bleeding)
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Hypoaesthesia (reduced sense of touch or sensation)
- Limb discomfort (discomfort in leg)
- Muscle spasms (muscle contraction)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pain in extremity
- Peripheral coldness
- Peripheral swelling
60+:
- Arthralgia (joint pain)
- Erythema (redness of the skin)
- Local swelling (swelling at the site of some application of substance or injury)
What are the existing conditions these people have? *
- Acne (skin problems that cause pimples): 5 people, 35.71%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 14.29%
- Vitamin B12 Deficiency: 1 person, 7.14%
- Depression: 1 person, 7.14%
- Device Related Infection: 1 person, 7.14%
- Gastrointestinal Pain: 1 person, 7.14%
- Hepatic Enzyme Increased: 1 person, 7.14%
- Hypervolaemia (abnormally increased volume of blood): 1 person, 7.14%
- Hypotension (abnormally low blood pressure): 1 person, 7.14%
- Ill-Defined Disorder: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Entyvio and Hydroxocobalamin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Entyvio (23,827 reports)
- Hydroxocobalamin (4,273 reports)
Browse all drug interactions of Entyvio and Hydroxocobalamin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Entyvio:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Hydroxocobalamin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Entyvio and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hydroxocobalamin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on vedolizumab and hydroxocobalamin (the active ingredients of Entyvio and Hydroxocobalamin, respectively), and Entyvio and Hydroxocobalamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Midostaurin and Valacyclovir - 2 seconds ago
- Singulair and Nasal Decongestion Therapy for Men aged 30-39 - 3 seconds ago
- Singulair and Stuffy Nose for Men aged 30-39 - 3 seconds ago
- Singulair and Nose - Congested for Men aged 30-39 - 3 seconds ago
- Singulair and Congested Nose for Men aged 30-39 - 4 seconds ago
- Singulair and Nasal Congestion for Men aged 30-39 - 4 seconds ago
- Escitalopram Oxalate vs. Metronidazole, side effect and effectiveness comparison - 25 seconds ago
- Drug interactions of Belbuca and Hydrocodone - 30 seconds ago
- Idiopathic Pulmonary Fibrosis and Celiac Disease - Sprue - 36 seconds ago
- Could Azilect cause Swelling? - 44 seconds ago